COMP <GO>
ACLS vs VICR // EV/EBITDA & P/E VALUATION
Axcelis Technologies Inc. (NASDAQ) VS. Vicor Corporation (NASDAQ) • 15-METRIC TALLY: ACLS 5
— VICR 7
▲ EV/EBITDA & P/E VALUATION LEADER: ACLS
LAST: $100.07 (-10.67%) • MKT CAP: $3.46B
valuation
25.7x
LAST: $191.09 (-7.52%) • MKT CAP: $9.54B
valuation
92.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACLS VS. VICR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACLS | VICR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.90% | 63.60% | -18.70 | VICR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.60% | 8.50% | +2.10 | ACLS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 25.7x | 92.5x | -66.80 | ACLS | /valuation <GO> |
| Free Cash Flow Yield | 3.09% | 1.25% | +1.84 | ACLS | /fcf-yield <GO> |
| Operating Margin | 14.20% | 20.10% | -5.90 | VICR | /operating-margins <GO> |
| Net Profit Margin | 14.30% | 29.10% | -14.80 | VICR | /net-margins <GO> |
| Revenue Growth (YoY) | -17.60% | 13.50% | -31.10 | VICR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.43 | 26.00 | -17.57 | VICR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 9/9 | -4.00 | VICR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.5 | 45.4 | +1.10 | ACLS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.26 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.8x | 67.5x | -40.70 | ACLS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.46B | $9.54B | -$6.08B | VICR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACLS REV | VICR REV | ACLS GROSS % | VICR GROSS % | ACLS FCF | VICR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $839.0M | $407.7M | 44.9% | 63.6% | $107.0M | $119.2M |
| FY 2024 | $1.02B | $359.1M | 44.7% | 51.2% | $128.6M | $27.2M |
| FY 2023 | $1.13B | $405.1M | — | — | $156.9M | $56.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACLS // BETA —
VICR // BETA 1.26